LFA-based Cardiac Marker Market Revenue 2024 to 2034

The LFA-based Cardiac Marker Market will expand from USD 2.92 Bn in 2024 to USD 6.45 Bn by 2034, growing at a CAGR of 8.3% over the forecast period.

Report ID: 10291 | Format: Databook | Published: August 2025 | Delivery: Immediate

Revenue,

USD USD 2.92 Bn

Forecast Year,

USD USD 6.45 Bn

CAGR, 2025 -

8.3%

Report Coverage

Worldwide

Reviewed By

Reviewed By

LFA-based Cardiac Marker Market Size Analysis

Marker	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Troponin	1.28	1.40	1.51	1.63	1.76	1.91	2.06	2.23	2.42	2.61	2.82
BNP/NT-proBNP	0.64	0.69	0.75	0.81	0.88	0.95	1.03	1.11	1.20	1.31	1.41
CK-MB	0.41	0.44	0.48	0.51	0.55	0.60	0.65	0.70	0.76	0.83	0.90
Myoglobin	0.29	0.32	0.34	0.37	0.41	0.44	0.47	0.51	0.56	0.60	0.65
Others	0.29	0.32	0.35	0.38	0.41	0.44	0.48	0.52	0.57	0.61	0.66

Product	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Kits & Reagents	2.45	2.66	2.88	3.12	3.38	3.66	3.97	4.30	4.65	5.03	5.45
Readers (Benchtop/Handheld)	0.47	0.50	0.54	0.58	0.63	0.68	0.73	0.79	0.85	0.93	1.00

End-User	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospitals	1.17	1.27	1.36	1.47	1.59	1.72	1.87	2.03	2.18	2.37	2.56
POC/Clinics	0.99	1.07	1.17	1.27	1.38	1.50	1.61	1.74	1.89	2.03	2.21
Diagnostic Labs	0.53	0.57	0.62	0.67	0.72	0.78	0.84	0.92	0.99	1.08	1.17
Others	0.23	0.25	0.27	0.30	0.32	0.35	0.37	0.41	0.44	0.48	0.52

Region	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
North America	1.23	1.33	1.44	1.56	1.69	1.83	1.98	2.15	2.33	2.51	2.71
Europe	0.82	0.88	0.96	1.03	1.12	1.22	1.32	1.43	1.54	1.67	1.81
Asia Pacific	0.70	0.76	0.82	0.89	0.95	1.03	1.12	1.20	1.30	1.41	1.54
Latin America	0.09	0.09	0.10	0.11	0.12	0.13	0.14	0.15	0.17	0.18	0.20
Middle East & Africa	0.09	0.09	0.10	0.11	0.12	0.13	0.14	0.16	0.17	0.18	0.20

Get immediate access to Databook and enjoy the flexibility to upgrade whenever you’re ready!

Explore all plans Create my account